Table 2.

Age-adjusted and multivariable-adjusted^a,b odds ratio (OR) and 95% confidence intervals (95% CIs) of NAFLD according to current use of VMS use among hypertensive adults.

	Current use of VMS
	Nonusers	Current users
Cases/Non-cases	1,714/4,289	301/1,072
Age-adjusted OR (95% CI)	1 (Ref)	0.65 (0.54–0.77)
MV-adjusted OR (95% CI)	1 (Ref)	0.73 (0.58–0.92)

CI confidence intervals, NAFLD non-alcoholic fatty liver disease, OR odds ratio, VMS vitamin and mineral supplements.

^aAll results presented in this table are sampling-weighted estimates except the number of study participants.

^bMultivariable model was adjusted for age (quartiles), sex (male, female), household income level (quartiles), education level (elementary school, middle school, high school, college or higher), smoking status (never, past, current, missing), alcohol drinking status (never, past, ≤ 1 time/month, 2– ≤ 4 times/month, ≥ 2 times/week), regular exercise (no, yes), body mass index (< 18.5 kg/m², 18.5– < 23 kg/m², 23– < 25 kg/m², ≥ 25 kg/m²), waist circumference (cm, continuous), diabetes mellitus (no, yes), hypercholesterolemia (no, yes), number of comorbidities (0, 1, 2, 3, ≥ 4), serum triglyceride concentration (mg/dL, continuous), hypertension stage (stage1, ≥ stage2, other), current use of hypertension medications (no, yes), and intakes of total energy (quartiles) and fruits and vegetables (quartiles).